Scholar Rock

Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company leverages its proprietary platform to develop highly specific inhibitors of growth factor activation. Scholar Rock’s pipeline is primarily focused on targeting TGFβ (transforming growth factor beta) to address high unmet medical needs in areas such as neuromuscular diseases, fibrosis, and oncology.